Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin
NCT00697034 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2018-08-13
Summary
The purpose of this research study is to examine the role of nerves in the skin in psoriasis and to better understand the effects of capsaicin in psoriasis.In this study, capsaicin will be compared to a moisturizer (aquaphor ointment).
Conditions
Interventions
- DRUG
-
Capsaicin
natural alkaloid derived from hot chili peppers and activates vanilloid receptors that are also activated by endogenous cannabinoid anandamide applied three times daily
Sponsors & Collaborators
-
Wake Forest University
lead OTHER
Principal Investigators
-
Gil Yosipovitch, MD · Wake Forest University Health Sciences
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-06-30
- Primary Completion
- 2007-08-31
- Completion
- 2008-12-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Study of Scaling Disorders and Other Inherited Skin Diseases
NCT00001292 ·Status: COMPLETED
-
Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis
NCT00667134 ·Status: COMPLETED
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis
NCT02652065 ·Status: COMPLETED ·Phase: NA
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP
NCT05614128 ·Status: TERMINATED
-
Research in Skin Inflammation
NCT00026741 ·Status: COMPLETED
-
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
NCT01538862 ·Status: COMPLETED ·Phase: PHASE2
-
Pleiotropic Role of TRPV1 in Psoriasis Inflammation
NCT04848194 ·Status: COMPLETED ·Phase: NA
-
Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors
NCT00709878 ·Status: COMPLETED
-
Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
NCT02777775 ·Status: COMPLETED
-
Proof of Biological Activity of SAR100842 in Systemic Sclerosis
NCT01651143 ·Status: COMPLETED ·Phase: PHASE2
-
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001164 ·Status: COMPLETED
-
Determinants of Chronic Inflammatory Skin Disease Trajectories
NCT05928169 ·Status: RECRUITING
-
Epidermal Growth Factor Receptor Inhibition for Keratinopathies
NCT06545695 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Characterization and Functionality of Calcium Channels Cav1.4 of Th17 Lymphocytes in Human With Psoriasis
NCT04459780 ·Status: COMPLETED ·Phase: NA
-
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
NCT02471352 ·Status: RECRUITING
-
The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases
NCT00001505 ·Status: COMPLETED
-
Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis
NCT00043706 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Methods Validation Assessment for Study of Inflammatory Skin Disease
NCT03796806 ·Status: COMPLETED
-
Molecular Effects of Topical Calcipotriene on Morphea
NCT02411643 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
NCT00433485 ·Status: COMPLETED ·Phase: PHASE1
-
Calcinosis Reduction by Pyrophosphate in SSC
NCT04966416 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis
NCT07015060 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of Topical SLPI on Skin Wounds
NCT00005569 ·Status: COMPLETED ·Phase: PHASE1